EDSA · Edesa Biotech, Inc.
$4.65
-0.13 (-2.72%)
At close · Sep 2
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s ability to continue as a going concern is dependent on obtaining additional funding through financings, other strategic activities as well as via grants, to fund the development of its drug candidates. There can be no assurance that the Company will be successful in raising the necessary financing. These conditions indicate the existence of a material uncertainty that may cast substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$44.45M
Shares
9.64M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding EDSA
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | — | 70,436 | $572,645 | 0.00% | Long | 2026-06-30 | |
| Fidelity Extended Market Index Fund | FSMAX | 34,981 | $252,563 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | FSKAX | 13,536 | $97,730 | 0.00% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | FCFMX | 9,603 | $69,334 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 3,889 | $28,079 | 0.00% | Long | 2026-05-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 30 | $244 | 0.00% | Long | 2026-06-30 |
Showing 1–6 of 6 positions
Key facts
CIK
1540159
CUSIP
27966L306
13F (30d)
32 filings
30 filers
Visit website
Investor relations